Keros Therapeutics, Inc. - 8-K Filing
Keros Therapeutics approves $5 million share repurchase program following receipt of $20 million Takeda milestone payment. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $KROS
Keros Therapeutics approves $5 million share repurchase program following receipt of $20 million Takeda milestone payment. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $KROS